Royal Medical Health

Royal Medical Health operates as a physician-directed medical spa in Albuquerque, New Mexico, under the clinical oversight of Dr. Maryam Bornaei. The practice integrates aesthetic medicine with metabolic health interventions, providing services that range from neuromodulator injections and dermal filler treatments to GLP-1 receptor agonist therapies for weight management. Dr. Bornaei's approach emphasizes patient education and transparent communication about treatment options, pricing structures, and realistic outcome expectations for both cosmetic procedures and medical weight loss protocols.

The clinic's aesthetic portfolio includes botulinum toxin treatments for dynamic wrinkles, hyaluronic acid-based dermal fillers for volume restoration and lip augmentation, and various body contouring modalities. Royal Medical Health has developed protocols for GLP-1 peptide therapy, which mimics incretin hormones to regulate appetite and glucose metabolism. These weight loss programs incorporate medical monitoring, dosage titration based on individual response, and nutritional guidance to support sustainable metabolic changes. The practice maintains a product selection that balances clinical efficacy with cost considerations, addressing the financial accessibility questions that frequently arise in elective medical treatments.

Dr. Bornaei structures consultations to provide detailed information about procedural techniques, expected recovery parameters, and maintenance requirements for aesthetic treatments. For patients considering lip filler procedures, the clinic discusses anatomical considerations, product longevity, and strategies to achieve natural-looking results that align with facial proportions. The GLP-1 weight loss protocols begin with comprehensive metabolic assessments, including evaluation of contraindications and discussion of the physiological mechanisms behind appetite suppression and improved glycemic control. Patients receive specific guidance on injection techniques for self-administration, management of common side effects, and coordination with any existing medical conditions or medications.

The Albuquerque location serves patients seeking alternatives to traditional diet-and-exercise approaches for weight management, particularly those with metabolic syndrome markers or obesity-related health concerns. Royal Medical Health's patient interactions focus on answering procedural questions thoroughly, explaining the science behind peptide therapies and aesthetic injectables, and establishing realistic timelines for visible results. The clinic's pricing model is structured to provide clarity on treatment costs upfront, addressing one of the most common patient concerns in the medical aesthetics field. Follow-up protocols ensure that both aesthetic and metabolic health outcomes are tracked systematically.

Royal Medical Health differentiates itself in the Albuquerque medical spa market through its dual focus on aesthetic refinement and functional medicine applications like GLP-1 therapy. The practice maintains accessibility through flexible scheduling and a patient portal system that facilitates communication about treatment plans, product information, and post-procedure care instructions. Dr. Bornaei's clinical model prioritizes knowledge transfer, ensuring patients understand the pharmacology of injectables, the metabolic pathways affected by peptide therapies, and the evidence base supporting various treatment protocols. This educational emphasis addresses the information-seeking behavior evident in patient feedback, creating a foundation for informed decision-making about elective medical procedures and weight management interventions.